Impact of Tricuspid Regurgitation in Patients With Heart Failure and Mitral Valve Disease from a Nationwide Cohort Study

Amer N. Kadri, Rama D. Gajulapalli, Yasser M. Sammour, Johnny Chahine, Leen Nusairat, Mohamed M. Gad, Yasser Al-khadra, Adrian V. Hernandez, Florian Rader, Serge C. Harb, Samir Kapadia

Resultado de la investigación: Contribución a una revistaArtículo

Resumen

© 2019 Elsevier Inc. Concomitant heart failure (HF) and mitral valve disease (MVD) portend significant morbidity and mortality. Although associated Tricuspid regurgitation (TR) is a common occurrence in this scenario, it is not well known whether there are additional prognostic implications. We sought to assess whether coexistent TR is associated with higher readmission rates or increased mortality in patients with HF and MVD. We identified 1,520,871 encounters with a primary diagnosis of HF in the 2013 to 2014 Nationwide Readmission Database. We excluded patients without MVD, patients <18 years old, those with rheumatic heart disease and infective endocarditis. We also excluded patients who were discharged in December, hospital transfers, and cases where follow-up or outcomes were missing. Logistic regression was used to evaluate the association between baseline characteristics (including the presence of tricuspid valve disease), mortality as well as 30-day readmission rates. A total of 221,127 admissions with HF and MVD were identified. Median age was 79 years (IQR, 67 to 87), 55% were female, 2.7% died during hospitalization, and the 30-day readmission rate was 20.3%. Nearly 1/3 had concomitant TR (n = 78,356, 35%). The presence of TR was neither associated with elevated risk of mortality (hazard ratio 0.98, 95% confidence interval 0.93 to 1.04) nor 30-day readmission rate (odds ratio 1.01, 95% confidence interval 0.98 to 1.03). HF accounted for 33% of 30-day readmissions, while combined cardiac causes accounted for 54%. In conclusion concomitant TR in patients with HF and MVD was not associated with worse short-term outcomes in terms of inpatient hospital mortality and 30-day readmission rates.
Idioma originalInglés estadounidense
Páginas (desde-hasta)926-931
Número de páginas6
PublicaciónAmerican Journal of Cardiology
DOI
EstadoPublicada - 15 sep 2019
Publicado de forma externa

Huella Profundice en los temas de investigación de 'Impact of Tricuspid Regurgitation in Patients With Heart Failure and Mitral Valve Disease from a Nationwide Cohort Study'. En conjunto forman una huella única.

  • Citar esto

    Kadri, A. N., Gajulapalli, R. D., Sammour, Y. M., Chahine, J., Nusairat, L., Gad, M. M., Al-khadra, Y., Hernandez, A. V., Rader, F., Harb, S. C., & Kapadia, S. (2019). Impact of Tricuspid Regurgitation in Patients With Heart Failure and Mitral Valve Disease from a Nationwide Cohort Study. American Journal of Cardiology, 926-931. https://doi.org/10.1016/j.amjcard.2019.05.070